One of the key requirements of successful vaccination against rabies is the induction of a robust neutralizing antibody response against glycoprotein G, a key viral protein that facilitates the virus infection. The level of antibodies against the protein is considered as a surrogate marker of protection against rabies. These virus neutralizing antibodies protect against rabies by blocking viral entry into host cells.
